Leqembi 100 mg/mL concentrate for solution for infusion
*Company:
Eisai LtdStatus:
UpdatedLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) Leqembi (lecanemab) Patient Card
Risk Minimisation Materials
(Click to Download) Leqembi (lecanemab) A Guide for Healthcare Professionals
Risk Minimisation Materials
Eisai Ltd
Address:
EMEA Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire, AL10 9SN, UKMedical Information E-mail:
EUMedInfo@eisai.netTelephone:
+44 (0)208 600 1400Website:
https://www.eisai.eu